Bard PowerPort failures are caused by a basic defect in the catheter's material design, namely the inclusion of barium sulfate. When these particles become embedded without proper encapsulation or a protective coating, they degrade the catheter over time, paving the way for fracture, migration, infection, and thrombosis.
Each of the complications carries its own injury profile and settlement implications for affected patients.
The barium sulfate material defect
Barium sulfate is added to the catheter material to enhance visibility under X-ray imaging, providing radiopacity for proper placement and ongoing monitoring. The problem is that this additive weakens the catheter over time when not properly encapsulated. Over time, the material of the catheter deteriorates, and the possibility of it cracking or breaking increases.
Barium sulfate is abrasive, and without proper encapsulation, particles embedded in the catheter contribute to wear as the device flexes and moves inside the body. This creates weak spots that are prone to cracking or perforation. Pieces can break off and enter the bloodstream, while cracks can allow medications or fluids to leak into nearby tissue. A catheter in this condition also becomes a greater infection risk, which is especially serious for chemotherapy patients and others with compromised immunity.
Plaintiffs will use biomedical engineers, scientists, interventional radiologists, and infectious disease experts to explain the interaction between barium sulfate and catheter materials. Medical literature confirms that implanted venous port systems suffer catheter complications including fracture, thrombosis, migration, infection, and other failures recognized in clinical practice.
Four primary complications from device failure
The Bard PowerPort has been linked to four significant complications after implantation. Each complication type presents distinct injury patterns and settlement value considerations for affected patients.
- Fracture and embolism: The most severe is the propensity of the device to fracture because of the brittleness of the material. When fractures occur, fragments lodge in the vascular system, tear or puncture blood vessels, or travel through the bloodstream, creating embolism risk, internal bleeding, vascular damage, and the need for invasive retrieval procedures. Published case literature recognizes that late mechanical complications include catheter fracture and migration, with fractured fragments migrating into the heart or vascular system. Fracture-related injuries are among the strongest claims in litigation and produce the highest average settlement payouts.
- Migration and vascular injury: Migration after implantation can result from design defects that allow catheter components to break, detach, or lose structural integrity. Migration leads to tube displacement, loss of device function, tissue injury, and vascular damage. Patients face emergency imaging, surgical removal, delayed chemotherapy or antibiotics, and real psychological distress. A device meant to make treatment easier, when inserted into the body, carries both medical and emotional consequences that are hard to overstate.
- Infection and sepsis: Material deficiencies increase serious infection risk when the device fractures, degrades, or creates surface irregularities, allowing bacterial colonization. These infections are particularly dangerous because many PowerPort patients receive chemotherapy that weakens their immune systems. Port infections lead to hospitalization, IV antibiotics, surgical removal, sepsis, delayed cancer treatment, and, in severe cases, death. Infection cases can be strong when the medical record ties infection to the port and the patient suffered serious treatment delays or hospitalization.
- Thrombosis and blood clots: Irregular surfaces, degradation of material and failure of the device may interrupt blood flow and induce blood clot formation in blood vessels. Thrombosis can cause swelling, pain, restricted circulation, pulmonary embolism and permanent vascular damage. Pulmonary embolism can be fatal. Patients may require anticoagulation therapy, hospitalization, surgery or long-term follow-up. Cases involving pulmonary embolism, chronic swelling, permanent vascular injury, or ongoing anticoagulation tend to carry high settlement value.
Settlement value factors for PowerPort claims
PowerPort claim value rises substantially when device failure is clear, injury is severe, and doctors have to remove the device or retrieve fractured catheter pieces. Several specific factors increase settlement value:
- Fracture with imaging evidence: If there are imaging or retrieval records that demonstrate a failure, this provides a clear and objective mechanism of injury.
- Migration leading to vascular injury: If the device migrates away from its site of implantation, it usually requires emergency intervention and surgery.
- Infection with sepsis: The combination of IV antibiotics, hospitalization, port removal, and delayed treatment compounds the damage.
- Thrombosis with pulmonary embolism: Life-threatening blood clot episodes greatly increase settlement value.
- Surgical retrieval: The operative records provide objective evidence of injury and increase the recovery time, pain and cost.
- Treatment interruption: Disrupted chemotherapy or antibiotics causes additional serious harm to already vulnerable patients.
Fracture, migration, vascular injury, serious infection, thrombosis, pulmonary embolism, sepsis, or surgical removal are the complications most commonly found in the strongest Bard PowerPort cases, particularly when treatment delays and hospitalization are part of the record.
Atraxia Law evaluates Bard PowerPort device failure claims
If a Bard PowerPort caused you serious complications such as fracture, migration, infection, or thrombosis that required surgery or hospitalization, you may have grounds for compensation. Atraxia Law represents patients with strong device failure cases in the federal MDL. We will review your implant records, imaging studies, and surgical documentation to evaluate your claim.
